PG 1
Latest Information Update: 25 Sep 2021
At a glance
- Originator Ardea Biosciences
- Class Antibacterials; Peptide antibiotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 26 Jul 2001 Discontinued-Preclinical for Bacterial infections in USA (Unknown route)
- 08 Nov 1996 Preclinical development for Bacterial infections in USA (Unknown route)